ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,893.62
0.39%
US Tech 100
19,985.20
-0.08%
Dow Jones
43,389.60
0.00%
Brent Oil
72.935
0.00%
Bitcoin
92,732.32
2.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Hyloris Pharmaceuticals SA (HYL) Quote

Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA (HYL)

EU
3.54
0.24
( 7.27% )
Updated: 07:55:06
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.54
Bid
3.41
Ask
3.61
Volume
32,745
3.06 Day's Range 3.59
2.89 52 Week Range 13.30
Market Cap
99.12M
Previous Close
3.30
Open
3.30
Last Trade
69
@
3.54
Last Trade Time
07:43:59
Financial Volume
-
VWAP
-
Average Volume (3m)
10,724
Shares Outstanding
28,000,000
Dividend Yield
-
PE Ratio
-6.44
Earnings Per Share (EPS)
-0.55
Revenue
4.21M
Net Profit
-15.38M

About Hyloris Pharmaceuticals SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.hyloris.com
Headquarters
Liege, Liege, Bel
Founded
-
Hyloris Pharmaceuticals SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker HYL. The last closing price for Hyloris Pharmaceuticals was 3.30 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 2.89 € to 13.30 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares outstanding. The market capitalization of Hyloris Pharmaceuticals is 92.40 € million. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.44.

Ask ADVFN Intelligence (AI)

HYL Latest News

More News

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

March 14 2024
GlobeNewswire Inc.

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin...

March 14 2024
GlobeNewswire Inc.

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

March 08 2024
GlobeNewswire Inc.

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

February 27 2024
GlobeNewswire Inc.

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires...

February 14 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.12-24.03433476394.664.663.06220873.82350963DE
4-2.56-41.96721311486.16.163.06108524.63101932DE
12-2.8-44.16403785496.346.53.06107245.39357268DE
26-8.16-69.743589743611.711.72.89144995.71651039DE
52-8.96-71.6812.513.32.89123368.2830385DE
156-11.46-76.41519.12.89743910.96844416DE
260-7.21-67.069767441910.7519.12.89891011.43879428DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALAGOEPango SA
0.0887 €
(22.85%)
3.23M
ALLAMLlama Group SA
0.736 €
(14.11%)
61.66k
BIOSBiosenic
0.006 €
(13.21%)
4.49M
SEQUASequana medical NV
0.87 €
(12.99%)
195.24k
MLCOUCourbet
1.30 €
(11.11%)
530
ATODSAtos SE
0.0047 €
(-54.81%)
6.22M
MLBSPBlue Shark Power System SA
6.55 €
(-22.94%)
200
EMGDSEuromedis DS
0.0116 €
(-22.67%)
9.28k
MHMMyHotelMatch
0.465 €
(-22.24%)
21.44k
EBUSEbusco Holding NV
1.21 €
(-19.87%)
392.45k
BCPBanco Comercial Portugues SA
0.4391 €
(-1.90%)
24.9M
ALNRGEnergisme SA
0.006 €
(0.00%)
14.37M
ALNEVNeovacs
0.0002 €
(0.00%)
11.38M
ALHPIHopium SA
0.01 €
(2.04%)
6.23M
ATODSAtos SE
0.0047 €
(-54.81%)
6.22M

Discussion

View Full Feed
Winechemist Winechemist 2 minutes ago
Sure, keep in mind this is just my rough calculations and based on hypothetical scenarios:

$75M Current Products launched
$75M 5 ANDAs launching this is a conservative 7.5% market share (APAP/Oxy, Hydro/APAP, Methadone, Apap and Codeine, methotrexate)
$860M, this is the
API
oldstocks oldstocks 2 minutes ago
George we requested both of them to be put out on newswires. So it is not pathetic. They put news out on Linkedin but only a few of us go out there to see any updates.

So yes it is good to hit the wires to inform the uninformed that do not know about our companies
AFFU
PurpleCritter2001 PurpleCritter2001 2 minutes ago
Steve, can you describe for me how LWLG technically could be involved with Lightmatter's passage? I mean, where do you think they have even the slightest possibility of fitting in? This could be very important.

I'll wait. Thanks for sharing your expertise!

Purpl
LWLG
JakBqk JakBqk 2 minutes ago
Oh snap, trolls are digging into my past looking for anything they can twist 😄
Wow this guy is retired before age 50! Taught himself how to make money all by himself, can do whatever he wants whenever he wants to. Had a steady job for 20 years which means he's dependable and an amazin
PHIL
subslover subslover 2 minutes ago
PainReform Ltd. (the “Company”) is announcing that it will effect a reverse share split of the Company’s ordinary shares after market close on Wednesday, November 20, 2024, at the ratio of 1-for-4, such that each four (4) ordinary shares, no par value, shall be consolidated into one (1) ordinary sh
PRFX
Sodapop42 Sodapop42 2 minutes ago
LMAO
PHIL
oldman69 oldman69 3 minutes ago
Cool! Now where's Shane?
IQST
BDEZ BDEZ 3 minutes ago
Spirit airlines files for bankruptcy
Konaploinks Konaploinks 4 minutes ago
No sweat Jj I posted some more good news for ya on the nvda board. The monitor there has me on 1 post per day. He doesn’t get it. Oh well
IonQ is killing it from all angles. The Quantum advancements of late really boggle the mind. A lot of new companies that I’m sure will be bought up , j
IONQ
Stinger2014 Stinger2014 5 minutes ago
Do you see the 3bil back to treasury in Q3 fins? Still a mystery. TIA
CGAC
Trooperstocks Trooperstocks 5 minutes ago
$CBDW NEWS: 1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling
1606 Corp.
Tue, November 19, 2024 at 8:00 AM EST

In This Article: CBDW

SEATTLE, WA / ACCESSWIRE / November 19, 2024 / 1606 Corp. (OTC
CBDW
Louie_Louie Louie_Louie 5 minutes ago
No, Calabria won't be back, nor Mnuchin. You've seen neither one near or even talking to Trump or any of his campaign pose. Trump gave them a mandate and they failed. Calabria wishes he can be at treasury, lol, lol yeah that's not going to happen either. My guess??? He won't even be consulted t
navycmdr navycmdr 5 minutes ago
FNMA/FMCC - Boooom ! BAZINGA ! Lets Go !


https://investorshub.advfn.com/uimage/uploads/2024/11/19/jziygScreenshot_20241119_045826_X.jpg

https://x.com/real_human101/status/1858606771742334979?t=EZETVAs0_rs5wFV4xc0AJA&s=19
FMCC
i_like_bb_stock i_like_bb_stock 5 minutes ago
yes really feels like were gonna get going here now dilution behind us
AFFU
MR1906 MR1906 5 minutes ago
Took a Quick Look and the fins seem marginally improved. Thoughts?
TREP
Drugdoctor Drugdoctor 5 minutes ago
$TCBP (NASDAQ) is crazy cheap at .60. Market cap down to $349,000! Was 3.5 million a year ago. Book value $3.38/share
https://finance.yahoo.com/quote/TCBP/key-statistics/

[yt]5fp1Wv3J4aQ[/yt]
TCBP
pennystyle01 pennystyle01 5 minutes ago
I hope so 
m0n m0n 6 minutes ago
No one is PAID LoL Oh yes, the shorts are shaking LoL since 2018 LoL. LoL  Lets not forget those Korean Hedge Funds shorting I FU S too. LoL

LoL

LoL

LoL

The Comedy Gold is so Pure LoL
IFUS
PEACHMAN PEACHMAN 6 minutes ago
One year ago today IFUS met with a group representing the consortium from India.Why do you continue to insist that The JOINT Venture in India is just one guy in a lot that is funding everything when multiple letters to shareholders state the truth


Another Letter Shareholders 1
IFUS
hweb2 hweb2 6 minutes ago
There's our huge quarter on UUU. Fiscal Q2 earnings of .25/share! Q2 revenues up 94%. I thought this low floater would be getting more of a pop, at least towards the $2.51/share buyout offer. As these strong results should reinforce the deal will go through in calendar Q1 2025. And if called of
Uncle Monkey Uncle Monkey 6 minutes ago
more excuses to come...

wait till they start blaming shareholders...
CBRF
Invest-in-America Invest-in-America 6 minutes ago
HCWB: Will it soar AGAIN, today?????????????????????????????
HCWB
tradernewstip tradernewstip 6 minutes ago
$CBDW News Out! Adnexus Biotechnologies Inc. Appoints Dr. Hiroshi Ohrui to Scientific Advisory Board https://finance.yahoo.com/news/adnexus-biotechnologies-inc-appoints-dr-120000868.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
CBDW
pennystyle01 pennystyle01 6 minutes ago
For real geezz

Your Recent History

EU
HYL
Hyloris Pharmaceuticals
USOTC
JNDAF
Jindalee Lithium (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved